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Ketanserin attenuates cigarette-mediated oxidative stress in human bronchial epithelial cells
WKW Lau1, ACK Law2, MSM Ip1, JCW Mak1,3
1Department of Medicine, The University of Hong Kong, Hong Kong
2Department of Psychiatry, The University of Hong Kong, Hong Kong
3Department of Pharmacology, The University of Hong Kong, Hong Kong
Introduction: Chronic obstructive pulmonary disease (COPD) is characterised by progressive airway limitation. 
Although the pathology of COPD is not fully understood, disruption of the oxidant-antioxidant homeostasis 
has been suggested to stimulate inflammatory reactions in the lung (Crapo, 2003). Cigarette smoke (CS), one 
of the major causes of COPD, is abundant in reactive oxygen species (ROS) that can induce oxidative stress. 
Ketanserin, a selective serotonin receptor 2 (5-HTR2) antagonist, has been reported to improve lung function in 
COPD patients (Cazzola et al, 1990) through unknown mechanisms. On the other hand, activation of 5-HTR2 has 
been suggested to generate ROS in rat renal mesangial cells (Greene et al, 2000). We therefore hypothesise that 
5-HTR2 is involved in CS-mediated oxidative stress, leading to inflammatory responses in the lungs. The present 
study aimed at investigating whether ketanserin protects bronchial epithelial cells from CS-induced oxidative 
stress and inflammatory responses. 
Methods: The human bronchial epithelial cell line (BEAS-2B) was cultured to 80% confluence in complete 
keratinocyte-SFM before treatment. Release of a pro-inflammatory marker, IL-8, was determined by ELISA. 
Oxidative stress was assessed by the ratio of reduced glutathione (GSH) to glutathione disulfide (GSSG) using 
spectrophotometric assay. 
Results: Our results demonstrated that CS significantly increased the IL-8 level (23.1±4.5 vs 8.5±0.9 pg/mL for 
CS-exposed and control cells respectively; P<0.01) and decreased the GSH/GSSG ratio (21.2±4.6 vs 43.9±10.5; 
P<0.001). Ketanserin (10 nM) completely reversed CS-induced IL-8 elevation and significantly restored CS-
induced oxidative stress. 
Conclusion: These data indicate the possibility that ketanserin may be beneficial in restoring CS-mediated 
oxidative stress and hence inflammatory responses. 
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Triiodothyronine promotes cardiac differentiation of embryonic stem cells through 
PI3K-Akt pathway
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Introduction: Thyroid hormones (3,5,3’-triiodothyronine [T3]) play a crucial role in cardiac physiology and are 
implicated in the development of cardiac hypertrophy. Thyroid gland and heart have close temporal and spatial 
relationship during embryonic development. The effects of T3 through cardiac foetal gene programming on 
adult cardiomyocytes have been well characterised; however, it is unclear whether T3 exerts any effects on 
cardiac differentiation of embryonic stem cells (ESCs).
Methods: Murine embryonic stem cell (mESC), D3, was used for cardiac differentiation in the current study. 
Troponin-T positive cells were counted as the ESC-derived cardiomyocytes (ESC-CM) by FACS. RT-PCR analysis 
revealed the mRNA expression of cardiac specific markers and calcium handling proteins. Furthermore, the 
calcium handling properties of ESC-CMs were examined by fluorescence confocal microscopy. The underlying 
mechanism of cardiac differentiation mediated by PI3-Akt pathway was studied by western blotting. 
Results: T3 promotes cardiac differentiation of ESCs as evidenced by an increase in the number of troponin-T 
positive cells counts. Consistently, mRNA levels of early and late cardiac markers including NK2 transcription 
factor–related locus 5 (Nkx 2.5), myosin light chain 2 ventricular transcripts (MLC2V), alpha- and beta-myosin 
heavy chain (A and B-MHC) are also increased with T3 treatment. Functionally, ESC-CMs treated with T3 appear 
to have a more mature calcium handling phenotype with a significant increase in the maximum upstroke 
velocity, which agreed with the up-regulated ryanodine receptor-2 (RyR2) level. Furthermore, inhibition of 
PI3/Akt signalling by LY294002 hence suggesting T3 induces cardiac differentiation and maturation via the Akt 
pathway.
52
